SCHEMBL7097156

SCHEMBL7097156

S=C(NCCN1CCCC1)Nc1ccc(Br)cn1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
LTC4S Q16873 1/20 0.57
FPR3 P25089 1/20 0.50
FPR2 P25090 1/20 0.50
ACHE P22303 2/20 0.46
TSHR P16473 1/20 0.46
SSTR2 P30874 2/20 0.45
SSTR4 P31391 2/20 0.45
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6229768 0.99 ALDH1A1 (0.57) ALDH1A1LTC4SFPR3FPR2ACHE
SCHEMBL30733352 0.82 ALDH1A1 (0.50) ALDH1A1LTC4SFPR3FPR2TSHR
SCHEMBL2320244 0.79 NMT1 (0.51) FPR3FPR2ACHETSHRNPC1
SCHEMBL13885949 0.79 ALDH1A1 (0.68) ALDH1A1LTC4STSHRSSTR4POLB
SCHEMBL1256229 0.78 NMT1 (0.53) FPR3FPR2ACHE
SCHEMBL6953144 0.78 ALDH1A1 (0.62) ALDH1A1LTC4SPOLBMAPTNPC1
SCHEMBL7224530 0.76 LTC4S (0.87) ALDH1A1LTC4STSHRSSTR4POLB
SCHEMBL29355043 0.74 ALDH1A1 (1.00) ALDH1A1LTC4SPOLBMAPTNPC1
SCHEMBL7624466 0.74 ALDH1A1 (1.00) ALDH1A1LTC4SPOLBMAPTNPC1
SCHEMBL12190202 0.74 ALDH1A1 (0.52) ALDH1A1TSHRCYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194427-B1 THIOPHENE-ETHYL THIOUREA COMPOUNDS AND USE IN THE TREATMENT OF HIV PARKER HUGHES INST (US) 2003-03-05 EP disclosed
US-6124324-A AN ENZYME INHIBITOR OF REVERSE TRANSCRIPTASE FOR THE TREATMENT OF HIV INFECTION, INCLUDING MUTANT, DRUG-SENSITIVE, DRUG-RESISTANT, AND MULTI-DRUG RESISTANT STRAINS OF HIV HUGHES INSTITUTE (US) 2000-09-26 US disclosed